Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioparker is a U.S. digital health joint venture formed by Biostrap and LCA Vantage Healthcare to provide interoperable electronic health record and remote physiologic monitoring solutions. The company markets a FHIR-compliant EHR/EMR platform branded as the SMART Tract ecosystem, designed to integrate continuous biometric monitoring with clinical workflow and data exchange. Its offering is positioned for healthcare providers, health systems, and government customers seeking interoperability, remote monitoring, and value-based care enablement rather than drug development. Based on available public information, Bioparker appears to operate as a commercial healthcare technology company rather than a therapeutics biotech or pharma developer. Publicly available evidence for a traditional drug pipeline, therapeutic targets, or clinical-stage assets was not identified.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioparker Corporation.